Nothing Special   »   [go: up one dir, main page]

Heinz et al., 1986 - Google Patents

A model study of the use of monoclonal antibodies in capture enzyme immunoassays for antigen quantification exploiting the epitope map of tick-borne encephalitis …

Heinz et al., 1986

Document ID
13870188439593710284
Author
Heinz F
Tuma W
Guirakhoo F
Kunz C
Publication year
Publication venue
Journal of biological standardization

External Links

Snippet

On the basis of an epitope model, capture enzyme immunoassay systems using monoclonal antibodies have been devised for the detection and quantification of Tick-borne encephalitis virus and compared with a reference system employing polyclonal sera. Monoclonal …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/576Immunoassay; Biospecific binding assay for hepatitis
    • G01N33/5761Hepatitis B
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/543Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • C07K16/1036Retroviridae, e.g. leukemia viruses
    • C07K16/1045Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24

Similar Documents

Publication Publication Date Title
Heinz et al. A model study of the use of monoclonal antibodies in capture enzyme immunoassays for antigen quantification exploiting the epitope map of tick-borne encephalitis virus
US5011771A (en) Multiepitopic immunometric assay
EP0158973A2 (en) Multisite immunometric assay
WO2007003090A1 (en) A composition instead of positive sera used as control in diagnostic agent and its application
US20030129587A1 (en) Antigen/antibody specificity exchanger
EP1328811B1 (en) Hcv mosaic antigen composition
US5091300A (en) Radio-immuno assay for hepatitis b virus pres2 antibodies
EP0904378A1 (en) Hepatitis b monoclonal antibodies
US4910131A (en) Idiotype and anti-idiotype antibodies useful in virus detection
KR870011154A (en) Diagnostic tests for manual and automated immunity against HTLV-III virus related peptides, antibodies, vaccines, AIDS virus and serological diagnosis of AIDS virus
US10634676B2 (en) Method and kit for simultaneously detecting human parvovirus B19 antigen and antibody
CN115806611B (en) Antibodies against novel coronavirus N proteins and uses thereof
CN104151399B (en) The shared specificity epitope of bocavirus (HBoV), its application and its antibody
CN114478716B (en) Polypeptide combination and application thereof in novel coronavirus antibody detection
Budkowska et al. A monoclonal antibody enzyme immunoassay for the detection of epitopes encoded by the pre-S2 region of the hepatitis B virus genome
Pujol et al. A double sandwich monoclonal enzyme immunoassay for detection of hepatitis B surface antigen
Van Regenmortel et al. Analysis of viral antigens using biosensor technology
CN116655779A (en) Novel coronavirus antibodies and uses thereof
Grieder et al. Antiidiotypic antibody mimicry of a bluetongue virus neutralizing antigen.
Nishio et al. Fecal IgA antibody responses after oral poliovirus vaccination in infants and elder children
Åkerlind‐Stopner et al. Evaluation of subgroup‐specific peptides of the G protein of respiratory syncytial virus for characterization of the immune response
Geltosky et al. Use of a synthetic peptide‐based elisa for the diagnosis of infectious mononucleosis and other diseases
JP2001133460A (en) High-sensitivity immunity measurement reagent of hepatitis b virus surface antigen
Ádám et al. Determination of different antigenic sites on the adenovirus hexon using monoclonal antibodies
McClure et al. Radioimmunoassay for anti-actin antibody: application in viral and autoimmune diseases